The survival analysis results suggested that MAP3K13 was a protective factor in HCC, and the bioinformatic analysis revealed that MAP3K13 was associated with the JNK signal pathway (Figures 1(a) and 7(g)). This evidence concerns the gene MAP3K13 and hepatocellular carcinoma.